The variable that matters in 2026 is not the TSA page. It is the airport you land at. A 28-airport breakdown of permissive, discretionary, and prohibitionist enforcement, with the source-state and destination-state details patients actually need.
NYC Local Law 97 emissions caps now apply to indoor cultivation tenants in covered buildings, with stricter 2030 limits driving retrofit planning today.
Regulators treat caffeine plus intoxicating cannabinoid drinks as a higher-risk category in 2025, raising ingredient ban, warning, and youth-appeal exposure.
Hemp-THC M&A buyers in 2025 underwrite regulatory survivability, discounting SKUs at risk under state caps, 4th and 8th Circuit rulings, and FTC exposure.
COA fraud in 2025 ranges from edited PDFs to mismatched lot IDs and Franken-COAs, pushing retailers toward digital signatures, raw data links, and audits.
New York OCM 2025 proximity correction recalculates dispensary spacing under Cannabis Law section 72(6), affecting over 100 licensees and pending applicants.
TSA updated its medical-marijuana page on April 27, 2026, one day before Schedule III took effect for state-licensed medical. Here is what changed for hemp, CBD, and medical-cannabis travelers — and the November 12 hemp cliff that resets everything.
New York, California, and Oklahoma cannabis lab suspensions in 2025 are driving retailer recalls, making rigorous Certificate of Analysis vetting essential.
New York OCM will move from BioTrack to Metrc in early 2026, giving cultivators, processors, and retailers a narrow 2025 window for data and training readiness.
The Second Circuit's August 12, 2025 Variscite ruling struck down New York's in-state cannabis conviction preference under the Dormant Commerce Clause.
New York's 2025 crackdown expanded padlock authority and revived a THC potency cap debate, forcing licensee action on enforcement and signage.
New York City has shuttered over 750 unlicensed cannabis shops under Operation Padlock, exposing licensed retailers and landlords to inspection risk.
New York OCM is weighing a 15 to 1 CBD-to-THC ratio rule for cannabinoid hemp products in 2025 alongside its existing ban on delta-8 and delta-10 isomers.
New York approved 52 adult-use cannabis licenses in May 2025 as states including Nebraska, Texas, and New Jersey opened new application windows for 2024-2025.
New York's projected $4.2 billion cannabis market by 2027 is hindered by licensing delays, strict packaging rules, and frequent regulatory shifts on operators.
AI-driven compliance tools help New York cannabis marketers vet ads, social posts, and email campaigns against state rules to avoid costly fines.
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
